Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors
Burdach, S.; Nürnberger, W.; Laws, H.J.; Engel, B.C.; Dirksen, U.; Krauth, K.; Pape, H.; Kahn, T.; Körholz, D.; Gadner, H.; Göbel, U.; Jürgens, H.
Bone Marrow Transplantation 18(Suppl 1): S67-S68
1996
ISSN/ISBN: 0268-3369 PMID: 8899179 Document Number: 468096
Document emailed within 1 workday
Related Documents
Stewart, D.A.; Gyonyor, E.; Paterson, A.H.; Arthur, K.; Temple, W.; Schachar, N.S.; Klassen, J.; Brown, C.; Russell, J.A. 1996: High-dose melphalan +/- total body irradiation and autologous hematopoietic stem cell rescue for adult patients with Ewing's sarcoma or peripheral neuroectodermal tumor Bone Marrow Transplantation 18(2): 315-318Zentilin, L.; Tafuro, S.; Serra, C.; Falaschi, A.; Giacca, M. 1998: Gene therapy of chronic granulomatous disease (CGD) by gene transfer into hematopoietic stem cells Annali Dell'istituto Superiore di Sanita 34(4): 447-455
Siena, S.; Bregni, M.; Di Nicola, M.; Magni, M.; Ravagnani, F.; Gandola, L.; Lombardi, F.; Gianni, A.M. 1996: Long-term hematopoietic reconstitution after myeloablative antitumor therapy and circulating hematopoietic stem cell transplantation Tumori 82(2 Suppl): S23-S27
Labidi, A.; Serghini, M.; Ben Mustapha, N.; Fekih, M.; Boubaker, J.; Filali, A. 2014: Stem cell transplantation as rescue therapy for refractory Crohn's disease: a sytematic review La Tunisie Medicale 92(11): 655-659
Yu, Z.; Zhou, F.; -Fu Ge, L.; Liu, X.-M.; Fang, Y.; Xie, L.; Kong, F.-S.; Song, N.-X. 2013: High-dose immunosuppressive therapy combined with cord blood infusion and non-myeloablative peripheral blood stem cell transplantation for patients with severe aplastic anemia European Review for Medical and Pharmacological Sciences 17(19): 2613-2618
Dass, B.; Olanow, C.Warren.; Kordower, J.H. 2006: Gene transfer of trophic factors and stem cell grafting as treatments for Parkinson's disease Neurology 66(10 Suppl 4): S89-S103
Armitage, J.O. 1992: Myeloablative regimens in peripheral stem cell transplantation Leukemia 6(Suppl 4): 88-89
Fagioli, F.; Ricchiardi, A.; Carnevale-Schianca, F. 2002: Non-myeloablative allogeneic hematopoietic stem cell transplants Haematologica 87(8 Suppl): 13-19
Cheong, S.-K.; Eow, G.-I.; Leong, C.-F. 2002: Non-myeloablative conditioning for hemopoietic stem cell transplantation--does it work? Malaysian Journal of Pathology 24(1): 1-8
Sullivan, K.M.; Goldmuntz, E.A.; Keyes-Elstein, L.; McSweeney, P.A.; Pinckney, A.; Welch, B.; Mayes, M.D.; Nash, R.A.; Crofford, L.J.; Eggleston, B.; Castina, S.; Griffith, L.M.; Goldstein, J.S.; Wallace, D.; Craciunescu, O.; Khanna, D.; Folz, R.J.; Goldin, J.; St Clair, E.William.; Seibold, J.R.; Phillips, K.; Mineishi, S.; Simms, R.W.; Ballen, K.; Wener, M.H.; Georges, G.E.; Heimfeld, S.; Hosing, C.; Forman, S.; Kafaja, S.; Silver, R.M.; Griffing, L.; Storek, J.; LeClercq, S.; Brasington, R.; Csuka, M.E.; Bredeson, C.; Keever-Taylor, C.; Domsic, R.T.; Kah 2018: Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma New England Journal of Medicine 378(1): 35-47
Bubeník, J.; Zeuthen, J.; Bubeníková, D.; Símová, J.; Jandlová, T. 1993: Gene therapy of cancer: use of IL-2 gene transfer and kinetics of local T and NK cell subsets Anticancer Research 13(5a): 1457-1460
Ruiz-Argüelles, G.J.; Gómez-Almaguer, D.; López-Martínez, B.; Cantú-Rodríguez, O.G.; Jaime-Pérez, Jé.C.; González-Llano, O. 2002: Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia Haematologica 87(8): 894-896
Matthay, K.K. 1996: Impact of myeloablative therapy with bone marrow transplantation in advanced neuroblastoma Bone Marrow Transplantation 18(Suppl 3): S21-S24
Mutschler, J.; Steinbach, G.; Bunjes, D.; Reske, S.N.; Buchmann, I. 2009: Myeloablative radioimmunotherapy with 188Re-CD66mAb before stem cell transplantation. no increase of proinflammatory cytokine levels of TNF-alpha NUKLEARMEDIZIN. Nuclear Medicine 48(1): 30-36
Kmonícek, M.; Jebavý, L.; Lánská, M.; Zák, P.; Malý, J.; Maisnar, V. 2000: The treatment of multiple myeloma with an allogeneic peripheral blood stem cell transplantation using a non-myeloablative conditioning regimen Vnitrni Lekarstvi 46(7): 377-383
Calne, R.Y.; Ghoneim, M.A.; Lee, K.O.; Uin, G.S. 2013: Gene and stem cell therapy for diabetes Clinical Transplants 2013: 111-112
Hoffman, R. 1995: Human hematopoietic stem cells: potential use as tumor-free autografts after high-dose myeloablative cancer therapy American Journal of the Medical Sciences 309(5): 254-259
Endo, M.; Tanosaki, R. 1995: Myeloablative chemotherapy with autologous bone marrow and/or peripheral blood stem cell transplantation in children with high-risk solid tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(12): 1762-1770
Federico, M.; Clò, V.; Carella, A.M. 1996: High-dose therapy autologous stem cell transplantation vs conventional therapy for patients with advanced Hodgkin's disease responding to first-line therapy: analysis of clinical characteristics of 51 patients enrolled in the HD01 protocol. EBMT/ANZLG/Intergroup HD01 Trial Leukemia 10 Suppl. 2: S69-S71
Duan, M.L.; Ulfendahl, M.; Ahlberg, A.; Pyykkö, I.; Borg, E. 2000: Future cure of hearing disorders? Gene therapy and stem cell implantation are possible new therapeutic alternatives Lakartidningen 97(10): 1106-1108; 1111-1112